霍乱
霍乱弧菌
霍乱疫苗
病死率
大流行
卫生
口服补液疗法
医学
卫生用品
环境卫生
免疫学
疾病
病毒学
2019年冠状病毒病(COVID-19)
传染病(医学专业)
人口
生物
卫生服务
内科学
细菌
病理
遗传学
作者
John D. Clemens,G. Balakrish Nair,Tahmeed Ahmed,Firdausi Qadri,Jan Holmgren
出处
期刊:The Lancet
[Elsevier]
日期:2017-09-01
卷期号:390 (10101): 1539-1549
被引量:306
标识
DOI:10.1016/s0140-6736(17)30559-7
摘要
Cholera is an acute, watery diarrhoeal disease caused by Vibrio cholerae of the O1 or O139 serogroups. In the past two centuries, cholera has emerged and spread from the Ganges Delta six times and from Indonesia once to cause global pandemics. Rational approaches to the case management of cholera with oral and intravenous rehydration therapy have reduced the case fatality of cholera from more than 50% to much less than 1%. Despite improvements in water quality, sanitation, and hygiene, as well as in the clinical treatment of cholera, the disease is still estimated to cause about 100 000 deaths every year. Most deaths occur in cholera-endemic settings, and virtually all deaths occur in developing countries. Contemporary understanding of immune protection against cholera, which results from local intestinal immunity, has yielded safe and protective orally administered cholera vaccines that are now globally stockpiled for use in the control of both epidemic and endemic cholera.
科研通智能强力驱动
Strongly Powered by AbleSci AI